Keyphrases
Atrial Fibrillation
90%
Primary Percutaneous Coronary Intervention
50%
ST-elevation Myocardial Infarction (STEMI)
50%
Incident Atrial Fibrillation
42%
Long-term Clinical Outcome
40%
Myocardial Infarction Patients
35%
Long-term Prognosis
25%
Ambulatory Cardiac Monitoring
20%
Ventricular Pauses
20%
Randomized Clinical Trial
20%
P-wave Indices
20%
Statistical Analysis Plan
20%
Primary PCI
20%
Real-world Experience
20%
Drug-eluting Metals
20%
Acute ST-segment Elevation Myocardial Infarction
20%
Field Triage
20%
Rate Control
20%
First-line Therapy
20%
Treatment Delay
20%
Randomized Trial
20%
Clinical Outcomes
20%
Poor Prognosis
20%
Aggressive non-Hodgkin Lymphoma
20%
Single Center
20%
Cardiac Function
20%
Clinical Trials
20%
Congestive Heart Failure
20%
Renal Function
20%
Bare Metal Stent
20%
Early Change
20%
Sinus Node Dysfunction
20%
Vascular Endothelial Growth Factor
20%
Serum interleukin-6
20%
Atrial Pacing
20%
Factor Level
20%
Beta-blockade
20%
Ectopic Activity
20%
Angiotensin-converting Enzyme Inhibition
15%
P-wave Area
13%
Syncope
13%
Pacemaker Implantation
12%
Hazard Ratio
11%
Persistent Atrial Fibrillation
10%
Confidence Interval
10%
Increased Mortality
10%
Diuretics
10%
Drug-eluting Stent
10%
Drug Use
10%
Rate-adaptive Pacing
8%
Medicine and Dentistry
Atrial Fibrillation
100%
ST Segment Elevation Myocardial Infarction
60%
Primary Percutaneous Coronary Intervention
50%
Percutaneous Coronary Intervention
20%
Sinus Node Disease
20%
Field Triage
20%
Therapy Delay
20%
Personal Experience
20%
Heart Atrium Pacing
20%
Enzyme Inhibition
20%
P Wave
20%
Randomized Clinical Trial
20%
Kidney Function
20%
Clinical Trial
20%
Congestive Heart Failure
20%
Dipeptidyl Carboxypeptidase
20%
Heart Function
20%
Beta Adrenergic Receptor Blocking
20%
Diuretic Agent
13%
Hazard Ratio
12%
Faintness
12%
Pacemaker Implantation
12%
Drug-Eluting Stent
10%
All Cause Mortality
7%
Presyncope
7%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
7%
Base
7%
Clinical Significance
6%
Short Form 36
6%
Supplementation
6%
Patient with Congestive Heart Failure
6%
Persistent Atrial Fibrillation
5%
Apoplexy
5%
Paroxysmal Atrial Fibrillation
5%
Drug Therapy
5%
Clinical Study
5%
